Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
NCT ID: NCT06184594
Last Updated: 2025-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
211 participants
INTERVENTIONAL
2024-01-24
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
NCT01032746
Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients
NCT06241768
Cancer Screening; Access; Awareness; Navigation
NCT04131946
Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations
NCT01853774
Peer Patient Navigation for Colon Cancer Screening
NCT02194959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. eNav group (N=200) or
2. usual care group (N=200)
Participants will consent and complete a baseline questionnaire (demographics, medical information) 1-4 weeks before their primary care appointment.
Those in the intervention group will receive a link to the eNav website. The digital navigation tool includes a website and text-messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).
The control group will receive standard clinical care.
Then 3-6 weeks after that primary care appointment, the research team will reach out to participants to complete a follow-up questionnaire. The follow up questionnaire will assess constructs guided by the health belief model (e.g., self-efficacy, benefits/barriers for CRC screening).
The impact of the eNav Toolkit on CRC screening completion at 6 months will be evaluated by checking their medical records. If a patient does not have a CRC screening recorded in their medical record, the research team will call the patient to inquire whether they have completed the CRC screening.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
eNav intervention
Subjects assigned to this arm will receive a link to the eNav website.
eNav
The eNav toolkit is a digital navigation toolkit that includes a website and text messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).
Usual Care Group
Subjects assigned to this arm will not receive the link to the website and will receive standard clinical care.
Standard of Care
Standard of care procedures for selecting their CRC screening test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
eNav
The eNav toolkit is a digital navigation toolkit that includes a website and text messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).
Standard of Care
Standard of care procedures for selecting their CRC screening test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient 45 to 75 years old
* English or Spanish speaking
* Able to provide consent within the study time frame (within a month of the primary care appointment
* Patients have access to a computer, tablet or mobile device to access the eNav Toolkit OR willing to use a clinic provided device, in person at either IFH OR Mount Sinai
* Patient scheduled for a primary care appointment at IFH
* Patients are due for colorectal cancer screening (as determined by the health maintenance alert in the medical chart)
Exclusion Criteria
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Institute for Family Health
OTHER
National Cancer Institute (NCI)
NIH
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Miller
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Miller, PsyD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-20-01888
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.